Clinical Trials Directory

Trials / Completed

CompletedNCT03795818

IPT-A for Adolescents With PTSD Symptoms

An Open Clinical Trial of Interpersonal Psychotherapy for Adolescents With PTSD Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
13 Years – 18 Years
Healthy volunteers
Not accepted

Summary

In the present study, the investigators propose to 1) adapt Interpersonal Psychotherapy for Adolescents (IPT-A) as an intervention for adolescents who report elevated symptoms of posttraumatic stress disorder (PTSD) and/or meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for PTSD; and 2) conduct a small open pilot study of IPT-A for PTSD. Ten adolescents ages 13 to 18 who meet DSM-5 criteria for a PTSD diagnosis or have elevated symptoms of PTSD (Child PTSD Symptom Scale \[CPSS-5\] ≥ 31) will be treated with 14-16 weeks of an adapted version of IPT-A. If participants have evidenced a decrease in PTSD symptoms (CPSS-5 \< 31) they will also receive 3 months of once a month maintenance treatment and be assessed by a clinician evaluator at the conclusion of the 3 monthly sessions. If participants have not evidenced a decrease in PTSD symptoms (CPSS-5 ≥ 31), they will be referred for alternative treatments in the community and be assessed by a clinician evaluator 3 months following the completion of IPT-A. All evaluations and therapy sessions will be done over telehealth platform until able to be done in person.

Detailed description

Please see the brief summary for study description.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInterpersonal Psychotherapy for AdolescentsIPT-A is a psychosocial intervention for adolescents that focuses on improving interpersonal relationships that seem to be associated with the psychiatric symptoms.

Timeline

Start date
2019-08-01
Primary completion
2023-06-12
Completion
2023-06-12
First posted
2019-01-08
Last updated
2024-02-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03795818. Inclusion in this directory is not an endorsement.